Co-Authors
This is a "connection" page, showing publications co-authored by Rémy Mostard and César Magro-Checa.
Connection Strength
0.349
-
Antibody response to SARS-CoV-2 in patients receiving glucocorticoids with or without tocilizumab for COVID-19-associated hyperinflammation. Ann Rheum Dis. 2021 10; 80(10):1362-1363.
Score: 0.236
-
Hemocytometric characteristics of COVID-19 patients with and without cytokine storm syndrome on the sysmex XN-10 hematology analyzer. Clin Chem Lab Med. 2021 03 26; 59(4):783-793.
Score: 0.057
-
Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study. Ann Rheum Dis. 2020 09; 79(9):1143-1151.
Score: 0.056